Teratogenic Drugs: Examples and Clinical Guidance
Pregnant women and women of childbearing potential must avoid specific medications with established teratogenic effects, including valproate, warfarin, lithium, isotretinoin, mycophenolate mofetil, ACE inhibitors/ARBs, streptomycin, thalidomide, and methotrexate, as these drugs cause serious structural birth defects and developmental abnormalities.
Established Teratogenic Medications by Category
Anticonvulsants
- Valproate (valproic acid): Causes neural tube defects, decreased IQ in exposed children, and multiple congenital anomalies; contraindicated in pregnancy and requires effective contraception in women of childbearing potential 1
- Phenytoin, carbamazepine, phenobarbital: Associated with congenital anomalies, particularly at higher doses and with polytherapy; monotherapy at lowest effective dose is preferred when anticonvulsants are necessary 2
Anticoagulants
- Warfarin: Causes warfarin embryopathy with characteristic facial and skeletal abnormalities, CNS malformations, and fetal death; absolutely contraindicated during pregnancy 3, 2
- Direct oral anticoagulants (DOACs): Limited human data but animal studies show placental transfer; should be avoided due to potential fetal bleeding risk 4
Cardiovascular Medications
- ACE inhibitors and ARBs: Cause fetal renal anomalies, oligohydramnios, fetal death, and neonatal renal failure; must be discontinued before conception 2
- Atenolol: Associated with lower birth weight and should be avoided 2
Dermatologic Agents
- Isotretinoin: Highly teratogenic causing craniofacial, cardiac, thymic, and CNS malformations; associated with miscarriage; requires strict contraception and pregnancy prevention programs 2, 5
Immunosuppressants
- Mycophenolate mofetil: Teratogenic and must be stopped at least 12 weeks before conception 6
- Methotrexate: Folate antagonist causing neural tube defects and multiple malformations; contraindicated in pregnancy 7
Antimicrobials
- Streptomycin: Documented to cause eighth nerve damage resulting in congenital deafness in 17% of exposed infants (ranging from mild hearing loss to bilateral deafness) 8
- Kanamycin, amikacin, capreomycin: Presumed to share ototoxic potential with streptomycin 8
- Fluoroquinolones: Associated with arthropathies in young animals; should be avoided if possible 8
Psychiatric Medications
- Lithium: Pregnancy Category D; associated with cardiac malformations (particularly Ebstein's anomaly); requires discontinuation and physician contact if pregnancy occurs 9
Endocrine Medications
- Methimazole: Possible teratogenicity in first trimester; propylthiouracil is preferred in first trimester, then switch to methimazole in second/third trimesters 2
Other Medications
- Thalidomide: Classic teratogen causing severe limb reduction defects (phocomelia) and multiple organ malformations 5
- Leflunomide: Teratogenic; requires washout period before conception 10
Teratogenic Mechanisms
The following mechanisms explain how medications cause birth defects 7:
- Folate antagonism: Methotrexate, trimethoprim, some anticonvulsants interfere with folate metabolism essential for neural tube closure 7
- Neural crest cell disruption: Isotretinoin, valproate affect neural crest migration causing craniofacial and cardiac defects 7
- Endocrine disruption: Methimazole, ACE inhibitors alter hormonal pathways affecting organ development 7
- Vascular disruption: Misoprostol, cocaine cause vascular insufficiency leading to tissue necrosis 7
- Oxidative stress: Phenytoin generates reactive oxygen species damaging developing tissues 7
Critical Timing Considerations
- Preimplantation period (0-4 weeks from last menstrual period): All-or-none effect—either miscarriage or complete recovery without malformation 4
- Organogenesis (4-8 weeks embryonic age, 6-10 weeks gestational age): Highest risk period for structural malformations 4
- Continued development (up to 20-22 weeks): Brain, genitalia, and palate remain vulnerable 4
- After 22 weeks: Risk of gross structural abnormality rare, but fetal toxicity and organ dysfunction remain concerns 4
Medications with Reassuring Safety Data
Generally Safe Throughout Pregnancy
- Acetaminophen: Safest analgesic option throughout pregnancy 11
- Penicillins and cephalosporins: Safe antibiotic options 8
- Insulin: Preferred for diabetes management 2
- Inhaled corticosteroids and beta-agonists: Safe for asthma control; budesonide and beclomethasone preferred 12
- Azathioprine, cyclosporine, tacrolimus, prednisolone: Should not be stopped in transplant recipients 6
Safe with Timing Restrictions
- NSAIDs (ibuprofen, diclofenac): Safe in first and second trimesters but must be discontinued after 28-32 weeks due to risk of premature ductus arteriosus closure and oligohydramnios 13
Common Pitfalls and Clinical Caveats
- Antidepressants (SSRIs): Despite concerns, converging evidence suggests observed associations between prenatal antidepressant exposure and neurodevelopmental problems (ASD, ADHD) are largely due to confounding factors rather than causal effects; untreated maternal depression poses significant risks 5
- Combination therapy: Multiple medications utilizing similar teratogenic mechanisms may have additive effects even if individually considered lower risk 7
- Timing of exposure: The same drug may cause different defects depending on gestational age at exposure 4
- Dose-response relationship: Higher doses and polytherapy increase malformation risk for anticonvulsants 2
Preconception Counseling Algorithm
- Identify all current medications and assess teratogenic potential 2
- Discontinue known teratogens with adequate washout period (mycophenolate: 12 weeks minimum) 6
- Switch to pregnancy-compatible alternatives when chronic treatment is necessary 2
- Optimize disease control before conception to minimize need for medication adjustments during pregnancy 2
- Ensure effective contraception until medication regimen is optimized 1
- Provide folate supplementation (at least 0.4-1 mg daily, higher doses for anticonvulsant users) 2